2013
DOI: 10.3892/mmr.2013.1860
|View full text |Cite
|
Sign up to set email alerts
|

Gankyrin is essential for hypoxia enhanced metastatic potential in breast cancer cells

Abstract: Hypoxia, a critical regulator of tumor growth and metastasis, induces the transcriptional activation of several pathways involved in proliferation, migration and invasion. Gankyrin was found to be overexpressed, and also promoted the metastasis in breast cancer cells, which is also involved in the regulation of hypoxia inducible factor‑1 and hypoxia‑inducible factor‑1α. The present study showed that gankyrin mRNA and protein expression were increased under hypoxic conditions in the BT474 breast cancer cell lin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
13
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(14 citation statements)
references
References 20 publications
1
13
0
Order By: Relevance
“…According to the literature, E‐cadherin is upregulated by ISG15 as well as by CLDN3 and FERMT2 shown in Table , which were all detected in MCS cells with higher LFQs than in controls. In addition, E‐cadherin is downregulated by MAPK8 and BCAR1, which are accumulated to a higher level in AD than in MCS cells, as well as by PSMD10 and SRC, which are absent in AD but present in MCS cells (Table ) . As our measurements clearly indicated a reduction of E‐cadherin in MCS cells, it may be concluded that the proteins effecting lower amounts of E‐cadherin are dominant.…”
Section: Resultssupporting
confidence: 49%
“…According to the literature, E‐cadherin is upregulated by ISG15 as well as by CLDN3 and FERMT2 shown in Table , which were all detected in MCS cells with higher LFQs than in controls. In addition, E‐cadherin is downregulated by MAPK8 and BCAR1, which are accumulated to a higher level in AD than in MCS cells, as well as by PSMD10 and SRC, which are absent in AD but present in MCS cells (Table ) . As our measurements clearly indicated a reduction of E‐cadherin in MCS cells, it may be concluded that the proteins effecting lower amounts of E‐cadherin are dominant.…”
Section: Resultssupporting
confidence: 49%
“…The aberrant expression of PSMD10 has been found in colorectal cancer, breast cancer, and liver cancer [4,20–22]. Aberrant PSMD10 expression has a function in tumor metastasis, proliferation, and drug resistance [4,6,22–24]. The results of the present study suggest that PSMD10 was directly targeted by miR‐605.…”
Section: Discussionmentioning
confidence: 53%
“…In addition, gankyrin deletion abrogated the increased metastatic potential of breast cancer cells under hypoxic conditions, partly through regulating E-cadherin [27]. Gankyrin was also found to maintain the stemness of colorectal cancer and control stem cell behavior by regulating the expression of stemness factors.…”
Section: Cellular Physiology and Biochemistrymentioning
confidence: 90%